Obicetrapib Shows Promise for Heart Disease and Alzheimer's Prevention
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
7 articles
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
Peter Attia answers listener questions on cardiovascular risk, metabolic health, minimum-dose strength training, dementia prevention, and NAD supplements.
Dr. Terry Simpson brings personal experience with FH, tirzepatide, and statins to a blunt takedown of health misinformation.
Discover breathing techniques that lower blood pressure and adaptive medicine strategies for optimizing health naturally.
Evidence-based training strategies for cardiovascular health, muscle strength, and longevity from leading exercise researchers.
Simon Hill's cardiovascular masterclass covers the Portfolio Diet, plaque regression, ApoB testing, and the sodium-potassium ratio with top experts.
Dr. Benjamin Levine reveals the specific exercise protocol that can turn back the clock on cardiovascular aging by two decades.